Varex Imaging (NASDAQ:VREX) Updates Q1 2025 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of -0.050-0.100 for the period, compared to the consensus estimate of 0.040. The company issued revenue guidance of $195.0 million-$215.0 million, compared to the consensus revenue estimate of $189.4 million. Varex Imaging also updated its Q1 guidance to $(0.05)-$0.10 EPS.

Analysts Set New Price Targets

Separately, B. Riley assumed coverage on shares of Varex Imaging in a research report on Friday, August 23rd. They set a “buy” rating and a $21.00 price target on the stock.

Varex Imaging Trading Up 3.1 %

Shares of VREX stock opened at $14.56 on Wednesday. Varex Imaging has a 1-year low of $10.19 and a 1-year high of $21.50. The firm has a market cap of $595.50 million, a PE ratio of 20.51 and a beta of 0.53. The company has a 50-day moving average of $12.35 and a two-hundred day moving average of $13.46. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.34 and a quick ratio of 1.89.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.